cervix

Cards (21)

  • Cervical dysplasia
    Replacement of one mature cell type with a less mature cell type, precancerous
  • Age group most at risk for cervical dysplasia and/or cervical cancer
    • 25-35 years old
  • Risk factors for high cervical cancer risk
    • Multiple partners and unprotected sex
    • HPV infection with HPV 16/other high risk types
    • Immunocompromised
    • Environmental factors/smoking
    • HSV
    • Chlamydia infection
    • Lower socioeconomic status
  • Association of HPV and cervical cancer
    HPV strains 16/18 cause cervical cancer
  • How HPV causes cervical cancer
    1. HPV likes immature basal cells of squamous epithelium and cells of squamocolumnar junction
    2. It makes viral proteins E6/E7 and inhibit tumor suppressor proteins (p53) to decrease DNA repair
    3. Increases cell turnover and causes increased mutations
  • Cervical cancer
    • Can be SCC or cervical adenocarcinoma
    • Grows very slow with associated hematogenous metastases
  • ASCUS
    Atypical Squamous cells of undetermined significance
  • ASC-H
    Atypical Squamous cells, cannot rule out high grade
  • LSIL
    Low grade squamous intraepithelial lesion; worse and associated with HPV+
  • HSIL
    High grade squamous intraepithelial lesion
  • CIS
    Carcinoma in situ
  • Signs and symptoms of cervical dysplasia/cancer
    • Asymptomatic at first
    • Abnormal vaginal bleeding
    • Vaginal discomfort
    • Vaginal discharge with unpleasant odor
    • Pain with urination
    • If metastasis beyond pelvic wall, symptoms of constipation/bloody urine
  • Physical exam findings of cervical dysplasia/cancer
    • Enlarged, irregular, firm cervix
    • Barrel-shaped cervical enlargement
    • Friable
    • Bleed
    • Cauliflower like lesions
    • Ulcerations
  • Diagnosis of cervical dysplasia/cancer
    Pap, colposcopy with cervical biopsy
  • Screening for cervical dysplasia/cancer should start at age 21
  • Pap smear screening schedule for ages 21-29
    Every 3 years
  • Pap smear screening schedule for ages 30-65
    Pap cytology and HPV every 5 years; pap cytology every 3 years
  • Discontinuation of Pap smear screening
    Discontinue at age 65 with negative consequence screens in last 10 years; screened for 20 years post treatment for CIN2,3
  • When to do colposcopy
    If no visible lesion but abnormal cervical cytology, test for above abbreviations and if positive do colposcopy and directed biopsies and endocervical sampling
  • If no cervix, no screening unless hysterectomy is performed for cervical cancer/precancer, then continue pap on vaginal cuff
  • HPV testing
    1. HPV positive: screen 2x in first year post diagnosis; yearly after
    2. Other immunocompromised conditions: screen yearly
    3. HPV testing on 21yo+ with ASC-US cervical cytology; triage test for LSIL in postmenopausal women; follow-up test on CIN I/neg colposcopy in women with ASC-US, ASC-H, LSIL, AGCs; follow-up after CIN II/III; just done with paps for 30yo+